Prof. Dr. med. Markus M. Nöthen
Institute of Human Genetics
markus.noethen@uni-bonn.de View member: Prof. Dr. med. Markus M. Nöthen
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
BACKGROUND: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher BE/EA risk. To facilitate understanding of biological factors that lead to progression from BE to EA, the present study investigated the shared genetic background of BE/EA and obesity-related traits.
METHODS: Cross-trait linkage disequilibrium score regression was applied to summary statistics from genome-wide association meta-analyses on BE/EA and on obesity traits. Body mass index (BMI) was used as a proxy for general obesity, and waist-to-hip ratio (WHR) for abdominal obesity. For single marker analyses, all genome-wide significant risk alleles for BMI and WHR were compared with summary statistics of the BE/EA meta-analyses.
RESULTS: Sex-combined analyses revealed a significant genetic correlation between BMI and BE/EA ( = 0.13, = 2 × 10) and a of 0.12 between WHR and BE/EA ( = 1 × 10). Sex-specific analyses revealed a pronounced genetic correlation between BMI and EA in females ( = 0.17, = 1.2 × 10), and WHR and EA in males ( = 0.18, = 1.51 × 10). On the single marker level, significant enrichment of concordant effects was observed for BMI and BE/EA risk variants ( = 8.45 × 10) and WHR and BE/EA risk variants ( = 2 × 10).
CONCLUSIONS: Our study provides evidence for sex-specific genetic correlations that might reflect specific biological mecha-nisms. The data demonstrate that shared genetic factors are particularly relevant in progression from BE to EA.
IMPACT: Our study quantifies the genetic correlation between BE/EA and obesity. Further research is now warranted to elucidate these effects and to understand the shared pathophysiology.
©2019 American Association for Cancer Research.
PMID: 31748258
Institute of Human Genetics
markus.noethen@uni-bonn.de View member: Prof. Dr. med. Markus M. Nöthen